FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q39505637> ?p ?o ?g. }

• Q39505637 description "2016 nî lūn-bûn" @default.
• Q39505637 description "2016年の論文" @default.
• Q39505637 description "2016年学术文章" @default.
• Q39505637 description "2016年学术文章" @default.
• Q39505637 description "2016年学术文章" @default.
• Q39505637 description "2016年学术文章" @default.
• Q39505637 description "2016年学术文章" @default.
• Q39505637 description "2016年學術文章" @default.
• Q39505637 description "2016年學術文章" @default.
• Q39505637 description "2016年學術文章" @default.
• Q39505637 description "2016年學術文章" @default.
• Q39505637 description "2016年學術文章" @default.
• Q39505637 description "2016年學術文章" @default.
• Q39505637 description "2016년 논문" @default.
• Q39505637 description "article científic" @default.
• Q39505637 description "article scientific" @default.
• Q39505637 description "article scientifique (publié 2016)" @default.
• Q39505637 description "articol științific" @default.
• Q39505637 description "articolo scientifico" @default.
• Q39505637 description "artigo científico (publicado na 2016)" @default.
• Q39505637 description "artigo científico (publicado na 2016)" @default.
• Q39505637 description "artigo científico" @default.
• Q39505637 description "artikull shkencor" @default.
• Q39505637 description "artikulong pang-agham" @default.
• Q39505637 description "artykuł naukowy" @default.
• Q39505637 description "artículo científico publicado en 2016" @default.
• Q39505637 description "artículu científicu espublizáu en 2016" @default.
• Q39505637 description "bilimsel makale" @default.
• Q39505637 description "bài báo khoa học" @default.
• Q39505637 description "mokslinis straipsnis" @default.
• Q39505637 description "naučni članak" @default.
• Q39505637 description "scienca artikolo" @default.
• Q39505637 description "scientific article" @default.
• Q39505637 description "teaduslik artikkel" @default.
• Q39505637 description "tieteellinen artikkeli" @default.
• Q39505637 description "tudományos cikk" @default.
• Q39505637 description "vedecký článok" @default.
• Q39505637 description "vetenskaplig artikel" @default.
• Q39505637 description "videnskabelig artikel (udgivet 2016)" @default.
• Q39505637 description "vitenskapelig artikkel" @default.
• Q39505637 description "vitskapeleg artikkel" @default.
• Q39505637 description "vědecký článek" @default.
• Q39505637 description "wetenschappelijk artikel" @default.
• Q39505637 description "wissenschaftlicher Artikel" @default.
• Q39505637 description "επιστημονικό άρθρο" @default.
• Q39505637 description "мақолаи илмӣ" @default.
• Q39505637 description "мақолаи илмӣ" @default.
• Q39505637 description "наукова стаття, опублікована в серпні 2016" @default.
• Q39505637 description "научна статия" @default.
• Q39505637 description "научная статья" @default.
• Q39505637 description "научни чланак" @default.
• Q39505637 description "научни чланак" @default.
• Q39505637 description "գիտական հոդված" @default.
• Q39505637 description "מאמר מדעי" @default.
• Q39505637 description "سائنسی مضمون" @default.
• Q39505637 description "مقالة علمية نشرت بتاريخ 9-8-2016" @default.
• Q39505637 description "مقالهٔ علمی" @default.
• Q39505637 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q39505637 description "บทความทางวิทยาศาสตร์" @default.
• Q39505637 description "სამეცნიერო სტატია" @default.
• Q39505637 name "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 name "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 name "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 type Item @default.
• Q39505637 label "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 label "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 label "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 prefLabel "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 prefLabel "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 prefLabel "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 P1433 Q39505637-E0A1488C-BBBF-4891-89F5-3576AF9B9948 @default.
• Q39505637 P1476 Q39505637-426A3531-7B0E-42BD-8297-76B7555B6F78 @default.
• Q39505637 P2093 Q39505637-03432EA9-BC7C-444C-81BA-888A877D554D @default.
• Q39505637 P2093 Q39505637-10B0BDF5-066F-4E3D-B7E3-0777EF9026FC @default.
• Q39505637 P2093 Q39505637-127D0993-43BD-4AFB-BE0C-E5020ABCA84E @default.
• Q39505637 P2093 Q39505637-16F898E9-4715-43BE-91C5-EE5FCEFFC286 @default.
• Q39505637 P2093 Q39505637-259CED5F-B1B1-42A2-B85B-290926AC8868 @default.
• Q39505637 P2093 Q39505637-2C659339-7580-4A41-9577-0921A669BC09 @default.
• Q39505637 P2093 Q39505637-475425B6-9B32-4BA1-A06B-EE2481B2B45A @default.
• Q39505637 P2093 Q39505637-6D3BB154-0FC1-40F7-8DE1-B1395E5177D5 @default.
• Q39505637 P2093 Q39505637-7A149467-CC03-41EE-9503-C549A42CBF32 @default.
• Q39505637 P2093 Q39505637-97DFA3FE-D21E-4248-B335-3E67BE9F2AD6 @default.
• Q39505637 P2093 Q39505637-BBF2BA66-EA83-4157-A088-D39A0FD49C4E @default.
• Q39505637 P2093 Q39505637-E04B7BB7-583C-4B4B-90FC-A25F930DB1A6 @default.
• Q39505637 P304 Q39505637-07EF1E3C-7093-4E7B-9DEE-854F24AA828C @default.
• Q39505637 P31 Q39505637-EBC1C963-53E6-407A-A022-B79087EEE99A @default.
• Q39505637 P356 Q39505637-9FF8352A-5634-4754-88A3-1EEDCB72096A @default.
• Q39505637 P407 Q39505637-EC9D99C3-C2B4-4E1F-BBA0-3227420C4350 @default.
• Q39505637 P433 Q39505637-34A1D38D-10EF-49DE-879E-2CFC5F0EBEFC @default.
• Q39505637 P478 Q39505637-9BC11316-D0E7-47E5-9D22-0238A6C51223 @default.
• Q39505637 P577 Q39505637-12AE943A-B213-489F-BDDB-4C8A58CC6A5E @default.
• Q39505637 P698 Q39505637-1D4AEBC9-F601-4B87-8E96-343F6B59D743 @default.
• Q39505637 P921 Q39505637-200DE72C-0D9F-4E83-9A0A-A0A5D4240874 @default.
• Q39505637 P921 Q39505637-37183D62-9570-4192-9F70-69713EBBEF1D @default.
• Q39505637 P921 Q39505637-C56F2F11-002D-4049-AEA8-DACC5C7DCFF7 @default.
• Q39505637 P356 JCO.2016.66.9218 @default.
• Q39505637 P698 27507876 @default.
• Q39505637 P1433 Q400292 @default.
• Q39505637 P1476 "Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations" @default.
• Q39505637 P2093 "Haruyasu Murakami" @default.

• next